Side-by-side comparison of AI visibility scores, market position, and capabilities
All-in-one business spend management platform with corporate cards, reimbursements, and AP automation for Asia-Pacific markets. Singapore, raised $29M+.
Volopay is a Singapore-based business spend management platform that provides corporate cards, expense management, reimbursements, and accounts payable automation to companies across Southeast Asia, India, and Australia. Founded in 2019 and headquartered in Singapore, Volopay has raised more than $29 million from investors including Accial Capital and Tinder co-founder Justin Mateen. The company was built to address the fragmented and inefficient financial operations typical of growing companies in the Asia-Pacific region, where mature spend management platforms have historically underserved local market needs.\n\nVolopay's platform provides Visa corporate cards with granular controls, a multi-currency wallet system for international payments, employee reimbursement automation, vendor payment management, and budget tracking across teams and departments. The platform's multi-currency capabilities are particularly valuable for Asia-Pacific businesses that deal with cross-border payments in multiple currencies regularly, providing competitive foreign exchange rates and transparent fee structures that simplify international spend management.\n\nThe company serves growth-stage startups and mid-market companies across Southeast Asia and has expanded its presence in India and Australia. Volopay competes with regional players including Aspire, Spenmo, and global platforms entering the Asia-Pacific market. Its integration with accounting systems popular in the region and its local regulatory compliance have helped it establish a growing customer base among technology companies, professional services firms, and e-commerce businesses that need modern spend management tools built for their specific operating context.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.